Influence of the circadian timing system on Tacrolimus pharmacokinetics and pharmacodynamics after kidney transplantation

dc.contributor.authorFontova, Pere
dc.contributor.authorColom Codina, Helena
dc.contributor.authorRigo Bonnin, Raúl
dc.contributor.authorvan Merendonk, Lisanne
dc.contributor.authorVidal Alabró, Anna
dc.contributor.authorMontero, Nuria
dc.contributor.authorMelilli, Edoardo
dc.contributor.authorMeneghini, Maria
dc.contributor.authorManonelles, Anna
dc.contributor.authorCruzado, Josep Ma.
dc.contributor.authorTorras Ambròs, Joan
dc.contributor.authorGrinyó Boira, Josep M.
dc.contributor.authorBestard Matamoros, Oriol
dc.contributor.authorLloberas Blanch, Núria
dc.date.accessioned2021-03-29T13:29:05Z
dc.date.available2021-03-29T13:29:05Z
dc.date.issued2021-03-17
dc.date.updated2021-03-29T13:29:05Z
dc.description.abstractIntroduction: Tacrolimus is the backbone immunosuppressant after solid organ transplantation. Tacrolimus has a narrow therapeutic window with large intra- and inter-patient pharmacokinetic variability leading to frequent over- and under-immunosuppression. While routine therapeutic drug monitoring (TDM) remains the standard of care, tacrolimus pharmacokinetic variability may be influenced by circadian rhythms. Our aim was to analyze tacrolimus pharmacokinetic/pharmacodynamic profiles on circadian rhythms comparing morning and night doses of a twice-daily tacrolimus formulation. Methods: This is a post-hoc analysis from a clinical trial to study the area under curve (AUC) and the area under effect (AUE) profiles of calcineurin inhibition after tacrolimus administration in twenty-five renal transplant patients. Over a period of 24 h, an intensive sampling (0, 0.5, 1, 1.5, 2, 3, 4, 6, 8, 12, 12.5, 13, 13.5, 14, 15, 20, and 24 h) was carried out. Whole blood and intracellular tacrolimus concentrations and calcineurin activity were measured by UHPLC-MS/MS. Results: Whole blood and intracellular AUC12-24 h and Cmax achieved after tacrolimus night dose was significantly lower than after morning dose administration (AUC0-12 h) (p < 0.001 for both compartments). AUE0-12 h and AUE12-24 h were not statistically different after morning and night doses. Total tacrolimus daily exposure (AUC0-24 h), in whole blood and intracellular compartments, was over-estimated when assessed by doubling the morning AUC0-12 h data. Conclusion: The lower whole blood and intracellular tacrolimus concentrations after night dose might be influenced by a distinct circadian clock. This significantly lower tacrolimus exposure after night dose was not translated into a significant reduction of the pharmacodynamic effect. Our study may provide conceptual bases for better understanding the TDM of twice-daily tacrolimus formulation.
dc.format.extent11 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec707698
dc.identifier.issn1663-9812
dc.identifier.pmid33815118
dc.identifier.urihttps://hdl.handle.net/2445/175857
dc.language.isoeng
dc.publisherFrontiers Media
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3389/fphar.2021.636048
dc.relation.ispartofFrontiers in Pharmacology, 2021, vol. 12
dc.relation.urihttps://doi.org/10.3389/fphar.2021.636048
dc.rightscc-by (c) Fontova, Pere et al., 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)
dc.subject.classificationRitmes circadiaris
dc.subject.classificationTrasplantament renal
dc.subject.classificationFarmacologia
dc.subject.otherCircadian rhythms
dc.subject.otherKidney transplantation
dc.subject.otherPharmacology
dc.titleInfluence of the circadian timing system on Tacrolimus pharmacokinetics and pharmacodynamics after kidney transplantation
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
707698.pdf
Mida:
1.29 MB
Format:
Adobe Portable Document Format